Seroatlas · Human Serome Atlas

TNFSF10

Tumor necrosis factor ligand superfamily member 10

Also known as: Apo-2L, CD253, TL2, TNF10_HUMAN, TRAIL

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P50591
Gene
TNFSF10
Ensembl
ENSG00000121858
Chromosome
3
Canonical length
281 aa
Protein class
Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters
Secretome location
Secreted to blood
Quaternary structure
Homotrimer

OverviewNCBI Gene

The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]

Canonical amino-acid sequenceUniProt

281 residues, UniProt reviewed canonical sequence.

>P50591|TNFSF10
     1  MAMMEVQGGP SLGQTCVLIV IFTVLLQSLC VAVTYVYFTN ELKQMQDKYS KSGIACFLKE
    61  DDSYWDPNDE ESMNSPCWQV KWQLRQLVRK MILRTSEETI STVQEKQQNI SPLVRERGPQ
   121  RVAAHITGTR GRSNTLSSPN SKNEKALGRK INSWESSRSG HSFLSNLHLR NGELVIHEKG
   181  FYYIYSQTYF RFQEEIKENT KNDKQMVQYI YKYTSYPDPI LLMKSARNSC WSKDAEYGLY
   241  SIYQGGIFEL KENDRIFVSV TNEHLIDMDH EASFFGAFLV G

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TNFSF10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
195 nTPM

Expression across tissuesHPA

Tissue

  • liver: 195 nTPM
  • lung: 167 nTPM
  • placenta: 158 nTPM
  • kidney: 135 nTPM
  • salivary gland: 129 nTPM
  • duodenum: 94 nTPM

Single-cell type

  • esophageal apical cells: 805 nCPM
  • prostatic hillock cells: 438 nCPM
  • respiratory secretory cells: 400 nCPM
  • prostatic club cells: 399 nCPM
  • neutrophils: 397 nCPM
  • extravillous trophoblasts: 372 nCPM

Immune cell

  • basophil: 266 nTPM
  • neutrophil: 258 nTPM
  • non-classical monocyte: 214 nTPM
  • intermediate monocyte: 204 nTPM
  • classical monocyte: 134 nTPM
  • total PBMC: 74 nTPM

Brain region

  • choroid plexus: 25 nTPM
  • medulla oblongata: 13 nTPM
  • pons: 11 nTPM
  • spinal cord: 11 nTPM
  • thalamus: 9.6 nTPM
  • white matter: 9.6 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.64
gnomAD pLI
0.13
gnomAD missense Z
0.17
DepMap mean gene effect
0.03
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TNFSF10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TNFSF10 as an antibody target. Whether an autoantibody or antibody against TNFSF10 could matter depends on whether native TNFSF10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TNFSF10 is annotated at the cell surface, where native TNFSF10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label TNFSF10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TNFSF10. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...